SCHEMBL4466816

SCHEMBL4466816

Nc1nccc(-c2ccc(N3CCOCC3)cc2)n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.66
CDK2 P24941 1/20 0.66
PIK3CD O00329 1/20 0.58
PIK3R1 P27986 1/20 0.58
PIK3CA P42336 1/20 0.58
PIK3CB P42338 1/20 0.58
RAB9A P51151 3/20 0.57
NPC1 O15118 2/20 0.57
KDM4E B2RXH2 3/20 0.56
MAPT P10636 2/20 0.56
ALDH1A1 P00352 2/20 0.56
JAK2 O60674 11/20 0.55
JAK3 P52333 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
GAA P10253 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
XDH P47989 1/20 0.52
ADK P55263 1/20 0.52
AURKA O14965 1/20 0.51
HSP90AA1 P07900 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1332294 0.86 RAB9A (0.59) CDK1CDK2PIK3CDPIK3R1PIK3CA
SCHEMBL30826811 0.85 CDK1 (0.62) CDK1CDK2PIK3CDPIK3R1PIK3CA
SCHEMBL2908002 0.85 CDK1 (0.62) CDK1CDK2PIK3CDPIK3R1PIK3CA
SCHEMBL30570935 0.84 HRH4 (0.59) CDK1CDK2RAB9ANPC1KDM4E
SCHEMBL29383512 0.83 CDK1 (0.57) CDK1CDK2PIK3CDPIK3R1PIK3CA
SCHEMBL28446714 0.82 JAK2 (0.55) PIK3CDPIK3R1PIK3CAPIK3CBRAB9A
SCHEMBL4033705 0.81 PIM1 (0.67) CDK1CDK2PIK3CDPIK3R1PIK3CA
SCHEMBL4383881 0.78 JAK2 (0.78) JAK2JAK3HDAC3NCOR1JAK1
SCHEMBL3725617 0.78 PIK3CA (0.72) CDK2PIK3CDPIK3R1PIK3CAPIK3CB
SCHEMBL7925159 0.78 PIK3CA (0.59) CDK1CDK2PIK3CDPIK3R1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed
CN-103483345-A Phosphoinositide 3-kinase (P13K) inhibitor, pharmaceutical composition containing P13K inhibitor, and application of phosphoinositide kinase inhibitor and pharmaceutical composition UNIV SUN YAT SEN 2014-01-01 CN disclosed
US-8334292-B1 Pyrimidine compounds and methods of making and using same CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2012-12-18 US disclosed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO disclosed